Osteoarthritis in the horse
Authors: Kidd J. A., Fuller C., Barr A. R. S.
Journal: Equine Veterinary Education
Summary
# Editorial Summary: Osteoarthritis in the Horse Equine osteoarthritis remains a significant clinical challenge, largely because conventional intra-articular treatments deliver drugs superficially with unpredictable release kinetics, limiting their therapeutic reach into damaged cartilage tissue. Kidd, Fuller and Barr examined a novel nano-delivery system—cationic mesoporous silica nanoparticles conjugated with cartilage-targeting peptides and loaded with fucoidan (a chondroprotective compound)—which was encapsulated within photocurable hydrogel microspheres for controlled, multi-stage release. In vitro studies demonstrated that this targeted nanoparticle-hydrogel system (CTNM@FU) successfully reversed impaired cartilage metabolism in cultured chondrocytes, whilst intra-articular administration in vivo not only reduced cartilage degeneration but actively promoted new cartilage formation through activation of the SIRT3 pathway, enhancing mitochondrial function and combating cellular ageing. The three-step programmable delivery mechanism—guided transport to injury sites, matrix penetration, selective cellular uptake and lysosomal escape—represents a significant departure from conventional bolus injections, potentially offering farriers, veterinarians and rehabilitation specialists a more effective tool for managing early degenerative joint disease. This spatiotemporal targeting approach warrants further investigation in equine clinical trials to establish whether it translates into improved functional outcomes and delayed progression in naturally occurring articular cartilage lesions.
Read the full abstract on PubMed
Practical Takeaways
- •This represents early-stage nanotechnology research with potential to improve drug delivery in joint injections, but is not yet applicable to clinical equine practice
- •The targeted delivery approach addresses a key limitation of conventional intra-articular injections—superficial penetration and uncontrolled drug release—that frustrates current OA management
- •Further development and in vivo equine studies would be needed before this technology could translate to therapeutic options for working horses with osteoarthritis
Key Findings
- •Cationic targeting nanoparticle-hydrogel microspheres (CTNM@FU) demonstrated three-step programmable transport to injured cartilage with selective chondrocyte entry and lysosomal escape
- •CTNM@FU reversed impaired cartilage metabolism in co-culture studies and mitigated cartilage degeneration while promoting de novo cartilage formation following intra-articular administration
- •The nanoparticle system protects cartilage by activating SIRT3, enhancing mitochondrial energy production and counteracting cellular aging mechanisms